Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
29.33
+0.04 (0.14%)
At close: Jun 3, 2026, 4:00 PM EDT
29.49
+0.16 (0.54%)
After-hours: Jun 3, 2026, 6:23 PM EDT
Viking Therapeutics Employees
Viking Therapeutics had 59 employees as of March 31, 2026. The number of employees increased by 13 or 28.26% compared to the same quarter last year.
Employees
59
Change
13
Growth
28.26%
Revenue / Employee
n/a
Profits / Employee
-$8,005,678
Market Cap
3.41B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Denali Therapeutics | 507 |
| Dyne Therapeutics | 263 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
VKTX News
- 6 days ago - Viking Therapeutics initiated with a Buy at Lake Street - TheFly
- 7 days ago - Viking Therapeutics assumed with a Buy at Truist - TheFly
- 13 days ago - Viking Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 22 days ago - Viking Therapeutics’ VK2735 demonstrates wieght loss in Phase 2 trial - TheFly
- 22 days ago - Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 - PRNewsWire
- 4 weeks ago - Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 - PRNewsWire
- 4 weeks ago - Viking Therapeutics price target lowered to $100 from $105 at Cantor Fitzgerald - TheFly
- 4 weeks ago - Viking Therapeutics price target lowered to $95 from $99 at Morgan Stanley - TheFly